Cargando…

Urotensin-II gene rs228648 polymorphism associated with the risk of diabetes mellitus

Background: Urotensin-II (UII) rs228648 polymorphism has been reported to be associated with the risk of diabetes mellitus (DM) with inconsistent results. The present study sought to reassess the relationship between this polymorphism and susceptibility to DM by meta-analysis. Methods: Relevant elig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yawei, Fang, Shuhua, Que, Kerong, Xu, Guangli, Zhang, Heng, Qi, Cong, Yang, Nian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435552/ https://www.ncbi.nlm.nih.gov/pubmed/30442870 http://dx.doi.org/10.1042/BSR20181275

Ejemplares similares

Urotensin II in cardiovascular regulation
por: Russell, Fraser D
Publicado: (2008)

Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout
por: Lancien, Frédéric, et al.
Publicado: (2017)

Irisin levels are associated with urotensin II levels in diabetic patients
por: He, Wan-Yu, et al.
Publicado: (2015)

Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells
por: Park, Sung Lyea, et al.
Publicado: (2013)

Divergent cardio-ventilatory and locomotor effects of centrally and peripherally administered urotensin II and urotensin II-related peptides in trout
por: Vanegas, Gilmer, et al.
Publicado: (2015)

Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines
por: Geyik, Sırma, et al.
Publicado: (2016)

Potential Clinical Implications of the Urotensin II Receptor Antagonists
por: Tsoukas, Philip, et al.
Publicado: (2011)

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits
por: Li, Yafeng, et al.
Publicado: (2014)

Urotensin-II: More Than a Mediator for Kidney
por: Balat, Ayşe, et al.
Publicado: (2012)

Blockade of Urotensin II Receptor Prevents Vascular Dysfunction
por: Kim, Young-Ae, et al.
Publicado: (2016)

Role of Urotensin-II in Saphenous Vein Graft Disease
por: Tüysüz, Mehmet Erin, et al.
Publicado: (2020)

Urotensin II levels in patients with inflammatory bowel disease
por: Alicic, Damir, et al.
Publicado: (2021)

Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures
por: Merlino, Francesco, et al.
Publicado: (2013)

A closer look at the role of urotensin II in the metabolic syndrome
por: Barrette, Pierre-Olivier, et al.
Publicado: (2012)

Urotensin II in Invertebrates: From Structure to Function in Aplysia californica
por: Romanova, Elena V., et al.
Publicado: (2012)

Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma
por: Portnoy, Alison, et al.
Publicado: (2013)

The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
por: Simunovic, Marko, et al.
Publicado: (2022)

Urotensin II level is elevated in inflammatory bowel disease patients
por: Zhang, Yan, et al.
Publicado: (2022)

Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction
por: Ogawa, Akiko, et al.
Publicado: (2023)

Urotensin II levels in patients with chronic kidney disease and kidney transplants
por: Hursitoglu, Mehmet, et al.
Publicado: (2012)

The urotensin II receptor antagonist, urantide, protects against atherosclerosis in rats
por: ZHAO, JUAN, et al.
Publicado: (2013)

Urotensin-II System in Genetic Control of Blood Pressure and Renal Function
por: Debiec, Radoslaw, et al.
Publicado: (2013)

The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification
por: Albanese, Isabella, et al.
Publicado: (2016)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

The value of urotensin II in patients with left-sided rheumatic valvular regurgitation
por: Elmadbouh, Ibrahim, et al.
Publicado: (2017)

Urotensin II promotes aldosterone expression in rat aortic adventitial fibroblasts
por: Li, Jun, et al.
Publicado: (2018)

Expression of urotensin II is associated with placental autophagy in patients with severe preeclampsia
por: Pan, Ya-Jing, et al.
Publicado: (2018)

Serum Urotensin II Levels Are Elevated in Patients with Obstructive Sleep Apnea
por: Mihovilovic, Ante, et al.
Publicado: (2023)

Urotensin II Exerts Pressor Effects By Stimulating Renin And Aldosterone Synthase Gene Expression
por: Caroccia, Brasilina, et al.
Publicado: (2017)

Endogenous Urotensin II Selectively Modulates Erectile Function through eNOS
por: d'Emmanuele di Villa Bianca, Roberta, et al.
Publicado: (2012)

Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells
por: Iglewski, Myriam, et al.
Publicado: (2010)

Lycopene Inhibits Urotensin-II-Induced Cardiomyocyte Hypertrophy in Neonatal Rat Cardiomyocytes
por: Chao, Hung-Hsing, et al.
Publicado: (2014)

The Relationship between Urotensin II and its Receptor and the Clinicopathological Parameters of Breast Cancer
por: Balakan, Ozan, et al.
Publicado: (2014)

The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow
por: Şatıroğlu, Ömer, et al.
Publicado: (2016)

Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2
por: Goldberg, Alexander A., et al.
Publicado: (2016)

Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients
por: Wei, Hongtao, et al.
Publicado: (2017)

Urotensin II in the development and progression of chronic kidney disease following ⅚ nephrectomy in the rat
por: Eyre, Heather J., et al.
Publicado: (2019)

A functional polymorphism rs10830963 in melatonin receptor 1B associated with the risk of gestational diabetes mellitus
por: Huang, Bo, et al.
Publicado: (2019)

Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits
por: Yu, Qing-qing, et al.
Publicado: (2019)

Is plasma urotensin II concentration an indicator of myocardial damage in patients with acute coronary syndrome?
por: Babińska, Magdalena, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tna2lcckg8743n5p6703rjc93s